- Title
- Results from RADIANT, a phase 2, randomized, open-label, sponsor-blinded study of CD101 topical in patients with moderate-to-severe acute vulvovaginal candidiasis
- Creators
- P. Nyirjesy - Drexel UniversityA. Jandourek - Cidara TherapeuticsJ. Lee - Cidara Therapeutics (United States)T. Sandison - Cidara TherapeuticsJ.D. Sobel - Wayne State University
- Publication Details
- American journal of obstetrics and gynecology, v 217(6), pp 715-715
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Decision Sciences (and Management Information Systems)
- Web of Science ID
- WOS:000416950700040
- Other Identifier
- 991019168747004721
Journal article
Results from RADIANT, a phase 2, randomized, open-label, sponsor-blinded study of CD101 topical in patients with moderate-to-severe acute vulvovaginal candidiasis
American journal of obstetrics and gynecology, v 217(6), pp 715-715
Dec 2017
Featured in Collection : UN Sustainable Development Goals @ Drexel
Metrics
19 Record Views
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Obstetrics & Gynecology